Depression

Focused Ultrasound Stimulation of the Prefrontal Cortex Treats Depression in Mice

by

A new study published in Frontiers in Psychiatry provides promising evidence that focused ultrasound stimulation of the prefrontal cortex can alleviate depressive behaviors in mice by suppressing inflammatory responses. Key facts: Researchers stimulated the prefrontal cortex of mice with focused ultrasound for 30 minutes. Mice treated with ultrasound showed less depressive behaviors compared to sham …

Read more

Focused Ultrasound (FUS): An Effective Treatment for Depression in Rat Study

by

New research demonstrates that repeated focused ultrasound treatments can have antidepressant-like effects in rats. The non-invasive technique was able to improve performance on a common test of depressive behaviors. While not a silver bullet solution, focused ultrasound represents an exciting potential alternative for depression treatment. Key Facts: Focused ultrasound (FUS) uses targeted sound waves to …

Read more

Fecal Microbiota Transplantation (FMT) for Depression Treatment: Targeting the Gut-Brain Axis

by

Fecal microbiota transplantation (FMT) shows potential as an effective new treatment for major depressive disorder (MDD). Key facts: FMT aims to restore a healthy gut microbiome which is thought to impact mood and mental health. Studies show links between gut microbiome abnormalities and depression. FMT has successfully treated depression symptoms in animal models. A few …

Read more

Low Neuregulin-1 (NRG-1) Linked to Obesity & Depression

by

A new case-control study reveals an association between obesity, depression, and decreased levels of the protein neuregulin-1 (NRG-1). The research suggests NRG-1 may serve as a biomarker linking depression and obesity. Key facts: Depressive symptoms were more common in obese individuals compared to normal weight controls. After bariatric surgery, most obese patients saw an improvement …

Read more

Caspase-3 (CASP3) & Depression: Low Gene Expression Impacts Neuroplasticity & Apoptosis

by

Major depressive disorder (MDD) is one of the most prevalent mental health conditions worldwide, yet its complex neurobiological underpinnings remain poorly understood. Emerging research implicates disturbances in neuronal apoptosis and neuroplasticity in the development of depression. A new study led by researchers in Poland sheds light on the involvement of caspase-3, a key mediator of …

Read more

High Remnant Cholesterol Linked to Depression in U.S. Adults: Possible Inflammatory Effects

by

A new study suggests higher levels of remnant cholesterol may increase the risk of depression. Remnant cholesterol is a type of lipoprotein that contains triglycerides and cholesterol and has been linked to atherosclerosis and cardiovascular disease. This large study found remnant cholesterol levels were significantly higher in people with depression compared to those without. Key …

Read more

Minocycline Adjunct Treatment for Depression via Immune-Inflammation Effects

by

Major depressive disorder (MDD) is a highly prevalent and debilitating condition. Novel treatment approaches are needed, especially for individuals with treatment-resistant depression. This study investigated the effects of adjunctive minocycline on immune-inflammatory biomarkers and clinical outcomes in MDD. Key Highlights: Minocycline is a broad-spectrum antibiotic with anti-inflammatory, immunomodulatory and neuroprotective properties. It shows promise as …

Read more

Biomarkers & Suicidal Ideation: Advanced Detection for Suicide Prevention

by

Suicide is a devastating public health problem, claiming hundreds of thousands of lives worldwide each year. Understanding the underlying biological and psychological factors that increase suicide risk is key for developing effective prevention and intervention approaches. A recent article comprehensively reviews research on biological markers of suicidal thoughts and behaviors, providing important insights and guidance …

Read more

Boost Serotonin in the Brain: Targeting TPH2 Enzymes to Treat Depression

by

Depression affects over 120 million people worldwide, carrying a heavy burden of disability, mortality, and cost. While medications like SSRIs have provided relief for many, most patients fail to achieve full remission. After 30 years with few advances in pharmaceutical options, it may be time to rethink our approach to treating depression. Exciting new research …

Read more

+ Load more